Guinea-Bissau stops a US-funded hepatitis vaccine trial involving babies, with sources reporting concerns that the study would deny critical vaccination to some infants. The trial is described as controversial and is halted before completion.

Both outlets cite criticism from experts and advocates who argue the trial’s design is ethically problematic. Al Jazeera focuses on the claim that thousands of infants would be left without the vaccine, framing the decision as a response to the potential impact on infant health. The BBC highlights how the trial is condemned as “unethical” and “neocolonial,” pointing to the plan that half of the babies would not receive the vaccine.

While the core facts are similar across coverage—Guinea-Bissau cancellation, US funding, and allegations tied to withholding vaccination—the emphasis differs between the projected scale of unvaccinated children and the broader ethical and geopolitical critique.